Literature DB >> 33759814

Functional genomics study of protein inhibitor of activated STAT1 in mouse hippocampal neuronal cells revealed by RNA sequencing.

Kan He1,2, Jian Zhang1, Justin Liu3, Yandi Cui1, Leyna G Liu4, Shoudong Ye1,2, Qian Ban1,2, Ruolan Pan1, Dahai Liu5.   

Abstract

Protein inhibitor of activated STAT1 (PIAS1), a small ubiquitin-like modifier (SUMO) E3 ligase, was considered to be an inhibitor of STAT1 by inhibiting the DNA-binding activity of STAT1 and blocking STAT1-mediated gene transcription in response to cytokine stimulation. PIAS1 has been determined to be involved in modulating several biological processes such as cell proliferation, DNA damage responses, and inflammatory responses, both in vivo and in vitro. However, the role played by PIAS1 in regulating neurodegenerative diseases, including Alzheimer's disease (AD), has not been determined. In our study, significantly different expression levels of PIAS1 between normal controls and AD patients were detected in four regions of the human brain. Based on a functional analysis of Pias1 in undifferentiated mouse hippocampal neuronal HT-22 cells, we observed that the expression levels of several AD marker genes could be inhibited by Pias1 overexpression. Moreover, the proliferation ability of HT-22 cells could be promoted by the overexpression of Pias1. Furthermore, we performed RNA sequencing (RNA-seq) to evaluate and quantify the gene expression profiles in response to Pias1 overexpression in HT-22 cells. As a result, 285 significantly dysregulated genes, including 79 upregulated genes and 206 downregulated genes, were identified by the comparison of Pias1/+ cells with WT cells. Among these genes, five overlapping genes, including early growth response 1 (Egr1), early growth response 2 (Egr2), early growth response 3 (Egr3), FBJ osteosarcoma oncogene (Fos) and fos-like antigen 1 (Fosl1), were identified by comparison of the transcription factor binding site (TFBS) prediction results for STAT1, whose expression was evaluated by qPCR. Three cell cycle inhibitors, p53, p18 and p21, were significantly downregulated with the overexpression of Pias1. Analysis of functional enrichment and expression levels showed that basic region leucine zipper domain-containing transcription factors including zinc finger C2H2 (zf-C2H2), homeobox and basic/helix-loop-helix (bHLH) in several signaling pathways were significantly involved in PIAS1 regulation in HT-22 cells. A reconstructed regulatory network under PIAS1 overexpression demonstrated that there were 43 related proteins, notably Nr3c2, that directly interacted with PIAS1.

Entities:  

Keywords:  AD; HT-22; PIAS1; RNA-seq; pathway

Year:  2021        PMID: 33759814     DOI: 10.18632/aging.202749

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  3 in total

1.  Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.

Authors:  Rebecca Panitch; Junming Hu; Weiming Xia; David A Bennett; Thor D Stein; Lindsay A Farrer; Gyungah R Jun
Journal:  Alzheimers Res Ther       Date:  2022-02-09       Impact factor: 6.982

2.  PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation.

Authors:  Jing Luo; Jiequn Li; Ting Li; Zhongqiang Zhang; Guangshun Chen; Qiang Li; Haizhi Qi; Zhongzhou Si
Journal:  Dis Markers       Date:  2022-08-31       Impact factor: 3.464

3.  Zbtb34 promotes embryonic stem cell proliferation by elongating telomere length.

Authors:  Zheng Liu; Xinran Wei; Yue Gao; Xiaodie Gao; Xia Li; Yujuan Zhong; Xiujuan Wang; Chong Liu; Tianle Shi; Jiabin Lv; Tao Liu
Journal:  Aging (Albany NY)       Date:  2022-09-12       Impact factor: 5.955

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.